focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Genus first-half profit hurt by declining pig prices in China

Thu, 24th Feb 2022 12:32

(Alliance News) - Genus PLC shares fell on Thursday after the firm reported lower interim revenue and profit due to reduced revenue in its Chinese PIC business and warned its second half will take a hit.

Shares were down 5.5% at 2,988.00 pence each on Thursday afternoon in London.

For the six months to December 31, the Basingstoke, Hampshire-based producer of biotechnology products for cattle and pig farmers posted a pretax profit of GBP24.4 million. This was down 35% from GBP37.4 million in the same period a year before.

Adjusted pretax profit declined 21% to GBP37.0 million from GBP47.1 million .

Revenue in the period fell 2% to GBP281.2 million from GBP285.7 million, year-on-year.

Genus blamed this on porcine market conditions in China. This led to a 4% decrease in revenue for PIC China, its porcine genetics business in the country. Genus said live pig price in China has remained below cost of production into January.

"Without PIC China, adjusted profit before tax would have grown by 28% in constant currency, due to robust growth across the rest of the group and prudent cost management," Genus stated.

Separately, Genus said it was expanding its Canadian business by acquiring the porcine genetics business of Olymel LP, AlphaGene, for CAD25 million and signed a strategic collaboration.

The collaboration combines PIC's expertise in porcine genetic improvement with Olymel's porcine production facilities, enabling Olymel's customers to benefit from improved AlphaGene health, efficiency and breakthrough technologies, Genus explained.

Genus' interim dividend remained flat at 10.3 pence per share.

Looking ahead, Genus expects that the China porcine market will continue to hamper its performance in the second half of financial 2022. It explained that this is due to uncertainty as to when and for how long pig prices and the overall porcine market will recover. However, its medium-term growth expectations remain unchanged.

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Related Shares

More News
30 Apr 2024 09:46

LONDON BROKER RATINGS: Deutsche says buy Barr, Britvic and Fevertree

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

21 Mar 2024 15:00

UK dividends calendar - next 7 days

22 Feb 2024 14:23

UK dividends calendar - next 7 days

22 Feb 2024 11:08

Genus touts programme to boost investment returns as profit declines

(Alliance News) - Genus PLC on Thursday reported a profit fall as its dairy business in China was "particularly" challenged, but said it took decisive...

22 Feb 2024 08:42

Genus holds gloomy guidance as tough conditions persist

(Sharecast News) - There were few surprises in Genus's interim results on Thursday after a detailed trading update from the animal genetics company ju...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.